FinCanna Capital Corp. (CSE: CALI), which raised approximately C$14m before commencing trading on the CSE on December 29, 2017, reiterates its business objectives for the benefit of its new shareholders.
FinCanna is a royalty company for the licensed medical cannabis industry which invests in sizable and scalable best-in-class businesses. The Company’s business objective is to provide capital solutions to top-tier companies with large scale potential and with highly skilled and experienced operators in exchange for a royalty based on a percentage of revenues.
FinCanna is focussed on California, the largest legal medical cannabis market in North America and the first state to legalize medical cannabis in 1996. FinCanna invests only in companies that operate ethically and in full compliance with all state laws and local regulations in the medical cannabis sector.
FinCanna’s flagship investment is in Cultivation Technologies Inc. (“CTI”) pursuant to a Funding Agreement dated April 20, 2017 between FinCanna and CTI (the “Funding Agreement”). CTI plans to construct in phases, a 111,500 ft2 facility on the Coachella Property, a six-acre property which it owns outright in Coachella, California. This will include an approximately 81,600 ft2 cultivation center to vertically grow indoor, ultra-premium medical cannabis in a controlled atmosphere without the use of chemical pesticides, a 9,000 ft2 extraction and manufacturing center and an additional 26,300 ft2 for testing, distribution, nursery, centralized processing and offices (the “Coachella Facility”).
CTI currently holds local permits for the Coachella Property that allow for construction of the project and permit CTI to conduct medical cannabis operations on-site, subject to regulatory requirements. Pursuant to the Funding Agreement, FinCanna has agreed to fund certain amounts of capital to CTI to purchase a royalty of 10% of CTI’s revenues.
CTI has also established an interim medical cannabis extraction facility (the “Interim Facility”) on the Coachella Property in accordance with CTI’s Conditional Use Permit. This lab will produce medical extracts for sale, is currently in operation, and is expected to remain in operation during the construction of the Coachella Facility. Currently, the Interim Facility can process an estimated 6,000 pounds of biomass per month which can produce approximately 3.7 million grams of raw oil per year. FinCanna is entitled to receive 50% of the profits of CTI which are derived from the Interim Facility.
FinCanna remains committed to its business objective of building its portfolio of investments by sourcing and funding additional top-tier companies and projects operating in the licensed medical cannabis sector in exchange for royalties on revenues.
Sponsored Content Release. Click for Full Disclosure
X
Disclaimer
Sponsored Content Release
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For this release, FinancialBuzz.com expects to be compensated five thousand dollars for financial news dissemination and PR services by fincanna capital corp. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.
Eric Karsh
Donald Trump, we (medical cannabis patients) were all counting on you to allow states to choose wether or not to allow medical marijuana. Now you're going back on your word???
Eric Karsh
Jan 08, 2018 at 11 48 amMaynard Keller
I work on medical cannabis reform 365/year, AND support Sessions staying on for 2 reasons: 1. the blowback's actually helping and 2. his being "recused on Russia" is the only thing standing between us and a constitutional crisis a replacement would cause #MMJ #DumpTrump #Sessions
Maynard Keller
Jan 08, 2018 at 01 06 pm